Free Daily Analysis
Index Trend Analysis Report
Prepared for you on Wednesday, July 30, 2025.
S&P Pan Asia BMI Pharmaceuticals, Biotechnology & Life Sciences (US Dollar) (CME:SPAU22)
Long-Term Uptrend (+90) - SPAU22 is in a strong uptrend that is likely to continue. While SPAU22 is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid SPAU22?
MarketClub looks at technical strength and momentum to determine if the timing is right for SPAU22.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for SPAU22
The long-term trend has been UP since Apr 28th, 2025 at 280.70
The intermediate-term trend has been UP since Jul 14th, 2025 at 297.87
The short-term trend has been UP since Jul 23rd, 2025 at 313.16
Smart Scan Analysis for SPAU22
Based on our trend formula, SPAU22 is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 320.75 | 320.79 | 316.04 | 316.09 | -4.59 |
| Prev. Close | Volume | Bid | Ask | Time |
| 320.68 | 0 | 2025-07-30 09:58:44 |
| 52wk High | 330.41 | 52wk High Date | 2018-09-27 |
| 52wk Low | 269.91 | 52wk Low Date | 2017-12-08 |